ABSTRACT

Introduction: Tamaka Swasa, as defined in Ayurveda, is a chronic disorder of the Pranavaha Srotasa involving Vata and Kapha Dosha and is comparable to bronchial asthma in contemporary medicine. Childhood bronchial asthma is a major public health concern due to recurrent episodes, reduced quality of life, and long-term dependence on conventional medications that may cause adverse effects. The Centres for Disease Control and Prevention reports that about 7.5% of children aged 5–11 years are affected by bronchial asthma. While modern management relies on bronchodilators and anti-inflammatory drugs, Ayurveda offers Swasahara and Rasayanaformulations to relieve symptoms, enhance Bala, and modify disease progression. This study aims to evaluate the comparative effectiveness of Bharangyadi Syrup and Vasa Avaleha Syrup in children with Tamaka Swasa. Methods: A randomized, controlled, parallel-group clinical trial will include 64 children aged 5–10 years with intermittent Tamaka Swasa. Participants will be equally divided into two groups and will receive either Vasa Avaleha Syrup or Bharangyadi Syrup for 60 days. Outcomes will be assessed using Ayurvedic symptom scoring, MPASS, PEFR, and C- ACT. Expected Results: Both formulations are expected to alleviate symptom severity and recurrence, with Bharangyadi Syrup anticipated to provide similar or enhanced benefits while also promoting better compliance. Conclusion: The study may validate a child-friendly Ayurvedic approach for pediatric bronchial asthma management. Keywords: Tamaka Swasa, Bronchial Asthma, Bharangyadi Syrup, Vasa Avaleha Syrup, Pediatric Ayurveda, Randomized Controlled Trial
Publication date: 2026/10/01

https://www.ijbpas.com/pdf/2026/October/MS_IJBPAS_2026_10539.pdf

Download PDF
doi.org/10.31032/IJBPAS/2026/15.10.10539